Aclaris Therapeutics, Inc. (ACRS)

$4.38 +6.83%

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-07 APPROXIMATE

Across 21 earnings reports since May 07, 2021, Aclaris Therapeutics, Inc. (ACRS) has a clear post-earnings pattern. It moves ±3.83% on average after reporting and finishes higher 52.4% of the time. Its largest post-earnings gain was +5.22% (Feb 24, 2022) and its largest decline was -10.87% (Nov 02, 2021). The next earnings report is predicted for 2026-08-07 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.83%

Positive %

52.4%

Negative %

47.6%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 07, 2026	☀ PRE	$4.68	$4.88	$4.87	76,051	+1.99%	open_in_new
Feb 26, 2026	☀ PRE	$3.17	$3.17	$3.13	1,576,600	-5.44%	open_in_new
Nov 06, 2025	☀ PRE	$2.29	$2.64	$2.27	2,838,700	+0.44%	open_in_new
Aug 07, 2025	☀ PRE	$1.55	$1.58	$1.57	612,000	+1.29%	open_in_new
May 08, 2025	☀ PRE	$1.28	$1.33	$1.31	1,061,900	+4.8%	open_in_new
Feb 27, 2025	☀ PRE	$2.17	$2.17	$1.95	640,700	-7.14%	open_in_new
Nov 06, 2024	☀ PRE	$2.24	$2.35	$2.26	578,600	+1.8%	open_in_new
Aug 07, 2024	☀ PRE	$1.28	$1.28	$1.19	1,220,400	-2.46%	open_in_new
May 07, 2024	☽ POST	$1.30	$1.36	$1.34	736,900	-8.96%	open_in_new
Feb 27, 2024	☀ PRE	$1.24	$1.37	$1.20	2,828,000	-0.83%	open_in_new
Nov 06, 2023	☀ PRE	$5.43	$5.71	$5.48	1,141,200	+2.05%	open_in_new
Aug 07, 2023	☀ PRE	$9.95	$9.95	$9.14	643,700	-7.21%	open_in_new
May 08, 2023	☀ PRE	$8.64	$8.73	$8.40	1,144,400	-6.46%	open_in_new
Feb 23, 2023	☀ PRE	$12.74	$13.09	$12.77	1,109,100	+0.63%	open_in_new
Nov 08, 2022	☀ PRE	$15.99	$16.30	$16.21	583,000	+4.31%	open_in_new
Aug 03, 2022	☀ PRE	$14.19	$14.77	$14.40	427,300	+1.41%	open_in_new
May 10, 2022	☀ PRE	$11.62	$11.85	$11.12	504,600	-0.27%	open_in_new
Feb 24, 2022	☀ PRE	$12.74	$14.40	$14.12	506,500	+5.22%	open_in_new
Nov 02, 2021	☀ PRE	$17.35	$17.71	$16.48	796,600	-10.87%	open_in_new
Aug 05, 2021	☀ PRE	$14.14	$15.19	$14.76	280,300	+3.14%	open_in_new
May 07, 2021	☀ PRE	$23.91	$24.38	$22.95	444,700	-3.69%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.83%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
8-K	20260604	open_in_new SEC.gov
10-Q	20260507	open_in_new SEC.gov
8-K	20260507	open_in_new SEC.gov
4	20260505	open_in_new SEC.gov

Frequently asked about ACRS earnings

When does Aclaris Therapeutics, Inc. report earnings next? expand_more

Aclaris Therapeutics, Inc. (ACRS)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ACRS stock move after earnings? expand_more

Over 21 reports, ACRS has moved an average of ±3.83% the session after earnings, closing higher 52.4% of the time.

What was ACRS's biggest post-earnings move? expand_more

ACRS's largest post-earnings gain on record was +5.22% on Feb 24, 2022, and its largest decline was -10.87% on Nov 02, 2021.

Where can I find Aclaris Therapeutics, Inc.'s SEC filings? expand_more

All of Aclaris Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.